글로벌 소아 방광 치료 시장 – 2030년까지의 산업 동향 및 예측

소아 방광 치료 시장 분석 및 규모

차가운 음료 마시기 및 화학 물질 노출과 같은 건강에 해로운 라이프스타일 채택은 소아 방광 치료 시장 성장을 촉진합니다. 나아가 소아 인구에서 불안과 비뇨기 질환의 증가와 전 세계적으로 최소 침습적 치료 옵션에 대한 수요가 증가함에 따라 글로벌 소아 방광 치료 시장이 증가할 것입니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 글로벌 소아 방광 치료 시장의 성장률을 분석합니다. 글로벌 부비동염 치료제 시장 의 예상 CAGR은  언급된 예측 기간 동안 약 4.00%인 경향이 있습니다. 시장은 2022년에 34억 달러로 평가되었으며 2030년까지 46억 5천만 달러로 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

소아 방광 치료 시장 범위 및 세분화

Market Definition

The pediatric bladder is a type of urological disease that is most common in children under 3 years old. A sudden urge to urinate occurs in the patient. The symptoms of the disease include regular urinary tract infections and a sudden urge to urinate. As per the report, around 17 to 20% of children may face urine incontinence during the day, and a further 6.6% may face problems at night. 

Global Pediatric Bladder Treatment Market Dynamics

Drivers

• Increased Incidence of Pediatric Bladder

Pediatric bladder is a prevalent condition. Additionally, it's estimated that this condition affects about 30% of children at age 4, 10% at age 7, 3% at age 12, and 1% at age 18. Thus, it boosts market growth.

• Rising Healthcare Expenditure

The healthcare expenditure includes all testing devices, healthcare services, family planning activities, and emergency kits designated for health. The factors determining the healthcare expenditure of any country are income (per capita GDP), technological progress and variation in medical practice, and health system characteristics. This healthcare expenditure helps organizations and government bodies increase the research activities on bladder treatment drugs, their upcoming clinical trials, and R&D activities. Thus, it boosts market growth.

Opportunities

• Increased Drug Launches

There have been increased drug launches that are helping in expanding the market growth. For instance, in April 2021, Medtronic plc announced approval from the US FDA to proceed with an investigational device exemption (IDE) trial to evaluate its internally developed implantable tibial neuromodulation (TNM) device, which is a therapy designed to provide relief from symptoms of bladder incontinence.

• The rise in Pediatric Population

The rising pediatric population is the main factor driving the market growth. According to surveys, in 2022, there will be 2 billion children worldwide aged 0 to 14 years old. This factor is projected to create opportunities in the forecast period.

Restraints/Challenges

• Side Effects of Bladder Drugs

The side effects associated with these pediatric bladder drugs could limit the growth of the global market over a forecast period. Effects such as rashes, loss of appetite, fever, fatigue, and constipation can hamper the market growth.

• Lack of Skilled Professionals

The lack of healthcare professionals unable to diagnose the condition and treat the same can hamper the market growth. Trained professionals are required for faster identification of the disease and immediate treatment process so that the recovery can be faster.

This global pediatric bladder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pediatric bladder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pediatric Bladder Treatment Market Scope

The global pediatric bladder treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diurnal Incontinence
• Enuresis
• Others

Treatment

• Urotherapy
• Medication
• Surgical Reconstruction
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Pediatric Bladder Treatment Market Regional Analysis/Insights

The global pediatric bladder treatment market is analyzed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global pediatric bladder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing the highest pediatric bladder treatment market growth throughout the forecasted period due to increased government awareness programs and the number of generic drugs.

North America dominates the market due to the presence of key manufacturers of the product, high research and development and healthcare expenditure, and skilled professionals

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pediatric Bladder Treatment Market Share Analysis

The global pediatric bladder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pediatric bladder treatment market.

Key players operating in the global pediatric bladder treatment market include:

• Pfizer Inc (U.S.)
• AstraZeneca (U.K.)
• Endo International plc (Ireland)
• Teva Pharmaceutical Industries Ltd (Israel)
• Sun Pharmaceutical Industries Ltd (India)
• Mylan N.V. (U.S.)
• Novartis AG (Switzerland)
• Aurobindo Pharma (India)
• Sanofi (France)
• Takeda Pharmaceutical Company Limited (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Orion Corporation (Finland)
• TherapeuticsMD, Inc. (U.S.)
• AbbVie Inc. (U.S.)
• AbbVie Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Amneal Pharmaceuticals LLC. (U.S.)
• Apotex Inc. (Canada)
• Aurobindo Pharma (India)

Research Methodology: Global Pediatric Bladder Treatment Market       

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 것을 자랑으로 생각합니다. 보고서는 타겟 브랜드의 가격 추세 분석, 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 타겟 경쟁업체의 시장 분석은 기술 기반 분석에서 시장 포트폴리오 전략까지 분석할 수 있습니다. 필요한 만큼 많은 경쟁업체를 원하는 형식과 데이터 스타일로 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 Excel 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용할 수 있는 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

SKU-55702